OverviewRetatrutide 30 is a research-grade triple-agonist peptide used to study signaling pathways associated with GLP-1, GIP, and glucagon receptors. Research FocusResearchers use Retatrutide 30 to investigate multi-receptor signaling integration, incretin-pathway modeling, and metabolic signaling cascades. Mechanism of InterestIts multi-agonist binding profile allows examination of receptor crosstalk and intracellular signaling events in metabolic models. Compliance NoticeFor research only. Not for human consumption.